又有33款高值耗材,被重点监控

2018-07-24 赛金花 赛柏蓝器械

又有33款高值医用耗材被重点监控,涉及48家医院。

又有33款高值医用耗材被重点监控,涉及48家医院。

7月23日,郑州市卫计委发布了《关于进一步加强医疗机构高值医用耗材重点监控工作的通知》。

通知要求,各医院应当根据河南省《高值医用耗材重点监控目录》、郑州卫计委制定的《郑州市高值医用耗材重点监控目录》,自身遴选的10种重点监控目录,结合医院高值医用耗材采购的情况确定重点监控产品。

每季度将市级监控目录中所包含的产品使用情况上报到市卫计委,各级卫生计生部门将对辖区内医院市重点监控目录产品采购情况,通过省公共资源交易中心监管平台不定期抽查,并统计、分析、通报。

对医院,则要求季度上报重点监控产品采购情况,每月对重点监控产品进行专项点评,并用信息化手段加强监控、使用评价。

同时,还要建立公示制度,每月对医师使用目录内高值耗材进行排名,使用金额前5的,要进行公示。对不合理使用高值耗材的医师,也要公示,公示内容包括医师姓名、高值耗材品种、使用数量等。

对于工作不力、违反相关规定的医院,将对其主要负责人进行诫勉谈话,督促整改,跟踪复查;对于存在 问题严重、整改不到位的,要严肃追究相关责任人的责任。督导检查结果将在一定范围内予以通报。

可以说,药品之后,高值耗材重点监控时代已经开始。被监控后,部分产品在监控区域内的销量可能出现断崖式下滑。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
    2018-07-25 易水河

    监督腐败啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
    2018-07-24 1e0f8808m18(暂无匿称)

    加大监管力度,保证药械安全。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1771985, encodeId=0ac11e71985f2, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Thu Dec 20 07:39:00 CST 2018, time=2018-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949090, encodeId=562919490909c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95895, encryptionId=72459589567, topicName=重点监控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93e223, createdName=bluefate121, createdTime=Mon Nov 26 20:39:00 CST 2018, time=2018-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484275, encodeId=3a5314842e5df, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Thu Jul 26 06:39:00 CST 2018, time=2018-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=334025, encodeId=0b8b33402588, content=监督腐败啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Wed Jul 25 08:11:57 CST 2018, time=2018-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333903, encodeId=8d67333903da, content=加大监管力度,保证药械安全。, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jul 24 20:23:57 CST 2018, time=2018-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=333897, encodeId=6bdd33389e20, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jul 24 19:45:26 CST 2018, time=2018-07-24, status=1, ipAttribution=)]
    2018-07-24 131****1460

    学习了受益匪浅

    0

相关资讯

青海省高值耗材不合理使用 院长、主任要追责

青海省卫计委制定了《青海省医疗质量提升活动方案(2017-2019年)》,将高值耗材的合理使用与院长、科主任的年度考核直接挂钩,并将院长、主任作为追责主要对象。

国际贸易市场风云变幻 我国医疗器械企业如何应对

国产医疗器械技术水平欠佳、制造水平不足一直是困扰我国医疗器械产业再上一个台阶的痛点。

高值耗材采购,贵州大标终于来了

自从去年12月9日贵州发布《关于公示<贵州省高值医用耗材网上阳光采购目录>的通知》后,日前,贵州第一批高值耗材集中采购终于正式启动了。

甘肃2020年将执行高值耗材两票制

第二次提出要执行高值耗材“两票制”,甘肃高值耗材“两票制”落地应跑不掉

卫计委紧急通知:控费未达标,医院降级!院长撤职!医务人员扣工资!

继贵州之后,又有一省将对公立医院医疗费用增长超标动手了。

今日“两票制”:山东提前,京沪严格要求

北京、上海同时发文,进一步对两票制的推行做出部署和要求;山东将在12月31日前全面启动执行“两票制”。